Trademark search for:

APMETEM

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2013-12-09 — Application filed
2013-12-12 — Application filed
2013-12-21 — Application filed
2014-03-18 — Attorney/dom.rep.revoked and/or appointed
2014-03-18 — Teas revoke/app/change addr of atty/dom rep received
2014-03-19 — Automatic update of assignment of ownership
2014-03-19 — Priority action written
2014-03-19 — Priority action e-mailed
2014-03-19 — Notification of priority action e-mailed
2014-03-19 — Assigned to examiner
2014-10-08 — Assignment of ownership not updated automatically
2014-10-15 — Application abandoned
2014-10-15 — Application abandoned
2014-10-15 — Final status recorded

Owner Information

ASTRAZENECA AB
SODERTALJE SE

Bristol-Myers Squibb Company
New York , NY

Correspondent

Marc Stanislawczyk AstraZeneca Pharmaceuticals LLP
1800 Concord Pike
FOP3-022
Wilmington, DE 19850-5437

Filing Details

Filing Date:
2013-12-09

Status Date:
2014-10-15

Category:
Pharmaceuticals

Filing Year:
2010

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.